CELL-PERMEANT PEPTIDE-BASED INHIBITOR OF KINASES

The described invention provides kinase inhibiting compositions containing a therapeutic amount of a therapeutic inhibitor peptide that inhibits at least one kinase enzyme, methods for treating an inflammatory disorder whose pathophysiology comprises inflammatory cytokine expression, and methods for...

Full description

Saved in:
Bibliographic Details
Main Authors PANITCH, ALYSSA, SEAL, BRANDON
Format Patent
LanguageEnglish
French
Published 18.07.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The described invention provides kinase inhibiting compositions containing a therapeutic amount of a therapeutic inhibitor peptide that inhibits at least one kinase enzyme, methods for treating an inflammatory disorder whose pathophysiology comprises inflammatory cytokine expression, and methods for treating an inflammatory disorder whose pathophysiology comprises inflammatory cytokine expression using the kinase inhibiting compositions. La présente invention concerne des compositions inhibitrices de kinases contenant une quantité thérapeutique d'un peptide inhibiteur thérapeutique qui inhibe au moins une enzyme kinase, des méthodes de traitement d'un trouble inflammatoire dont la pathophysiologie comprend l'expression d'une cytokine inflammatoire et des méthodes de traitement d'un trouble inflammatoire dont la pathophysiologie comprend l'expression d'une cytokine inflammatoire par l'emploi des compositions inhibitrices de kinases.
Bibliography:Application Number: CA20092744104